Typical Dental Partnership Buyout Terms for Senior Partners

Last updated: July 24, 2026

Key Takeaways for Senior Dental Partners

• Senior-partner dental buyouts in 2026 are often valued at 60–80% of collections for doctor-to-doctor deals or 4x–11x adjusted EBITDA for DSO transactions, depending on practice size and buyer type.
• Payment structures can vary. Doctor-to-doctor deals often combine a 75–90% cash down payment with seller-financed notes, while DSO transactions usually include cash at close, rollover equity, and earnouts.
• Restrictive covenants such as non-competes (2–5 years, 5–10 miles) and patient non-solicitation are common. Enforceability depends on state law and usually requires careful negotiation.
• Senior partners can negotiate protections such as a guaranteed minimum price, continued profit participation, health insurance continuation, and non-punitive earnout terms to safeguard their financial and personal interests.
• McLerran & Associates provides sell-side expertise to help maximize value and structure favorable terms. Contact the team for a confidential discovery call.

How Senior-Partner Buyouts Are Valued in 2026

Two formulas can be some of the main factors in dental partnership buyout valuation in 2026, and the applicable method usually depends on who the buyer is.

For doctor-to-doctor transactions, the most common benchmark is a percentage of trailing 12-month collections. General dentistry practices can sell at 60–80% of collections to solo buyers financed through SBA 7(a) loans, and healthy general practices can trade at roughly 60–80% of annual collections as a rule of thumb. For DSO and private-equity buyers, the anchor often shifts to a multiple of normalized adjusted EBITDA, which is the practice’s operating profit after replacing the owner’s compensation with a market-rate associate salary and removing personal or one-time expenses.

The following table summarizes 2026 valuation ranges by practice tier and buyer type.

Practice Tier	Collections / EBITDA Profile	Doctor-to-Doctor Range	DSO / PE Range
Solo, single-location GP	Under $500K SDE	60–80% of collections	4.0x–6.0x SDE
Associate-supported GP	$500K–$1M EBITDA	60–85% of collections	5.0x–8.0x EBITDA
Multi-location group	$1M+ EBITDA	Less common at this scale	8x–11x EBITDA
Emerging platform	$3M–$5M adjusted EBITDA	Rarely applicable	9x–11x EBITDA

A worked example can make these ranges more concrete. Consider a practice with $2M in annual collections and a 30% EBITDA margin after normalizing owner compensation to a market-rate associate salary of roughly $280,000–$300,000. That yields approximately $600,000 in adjusted EBITDA. At a 60–80% collections benchmark, the doctor-to-doctor value range is $1.2M–$1.6M. At a 5.0x–7.0x DSO multiple on $600,000 EBITDA, the DSO range is $3.0M–$4.2M. This spread highlights why understanding both markets can matter before choosing a path.

Several factors can move a multiple higher or lower within these ranges. Practices where the owner-doctor performs a high percentage of production can face a valuation reduction in DSO transactions because of key-person risk. Hygiene patient retention above 75% can lift acquisition multiples, while retention below 60% may trigger buyer concern about long-term revenue durability. Specialty mix can also influence ranges, though specific multiples by specialty usually require case-by-case evaluation.

McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis before any practice goes to market. This level of preparation can hold up when buyers scrutinize the numbers and can reduce the risk of deals being re-traded at a lower price later.

Request a confidential valuation discussion with McLerran & Associates to see what your practice may be worth in both the private-buyer and DSO markets.

How Payment Structure Works for Senior-Partner Buyouts

Once the purchase price is established using the valuation methods above, the next key question is how that price will be delivered. Payment structure depends heavily on whether the buyer is another dentist or a DSO.

In doctor-to-doctor transactions valued using the collections-based benchmarks discussed above, the standard capital stack in 2026 often looks like this:

• Down payment: Solo doctor buyers typically pay 75–90% cash at close, with the remainder covered by seller financing.
• Seller-financed note: Seller notes commonly include monthly principal-and-interest payments.
• SBA financing: SBA 7(a) loans for dental acquisitions in July 2026 typically require a 10% equity injection and carry Prime-based rates in the 10–13% APR range, with 10-year terms for practice-only purchases.

Applying this to the $2M collections example above, if the doctor-to-doctor sale price is $1.4M, a 15% seller note equals $210,000 paid over several years. That structure can create a predictable income stream for the retiring senior partner.

DSO transactions usually follow a different structure. The standard 2026 DSO payment structure often includes 60–85% cash at close, 10–30% rollover equity, and a 1–3 year earnout tied to post-close EBITDA maintenance. Rollover equity, which is a stake in the acquiring company retained by the seller, is effectively mandatory in many DSO structures. Deals are often structured as 60–75% cash at close, 15–30% rollover equity, and 5–15% earnout.

Interest rates in 2026 can also influence structures. Elevated interest rates have compressed debt-financeable single-office multiples by roughly 0.5x–1.0x from 2021 peaks, with Prime at 6.75% and SBA 7(a) loans priced at Prime plus 2.25–2.75% through the first half of 2026. Senior partners selling to individual buyers may want to factor this into pricing expectations. DSO buyers, who often use equity rather than SBA debt, are less directly affected.

Speak with a McLerran & Associates advisor to model the after-tax cash you might receive under different payment structures.

Restrictive Covenants in Senior-Partner Dental Buyouts

A restrictive covenant is a contractual restriction that limits what the selling senior partner can do after the transaction closes. In dental buyouts, these covenants protect the goodwill, meaning the patient relationships and reputation, that the buyer is paying for.

The most negotiated covenants in 2026 dental buy-sell agreements include the following items.

• Non-compete: This provision prevents the seller from practicing dentistry within a defined geographic area for a set period. Standard non-compete radius and duration ranges are 5–10 miles and 2–5 years, with metro markets typically at the lower end of both ranges because of population density.
• Non-solicitation of patients: Patient non-solicitation is typically permanent. The definition of “solicit” usually includes carve-outs for general advertising that is not targeted at former patients.
• Non-solicitation of employees: Employee non-solicitation typically runs 1–2 years and covers current staff at the time of closing.
• Confidentiality: This covenant restricts disclosure of practice financials, patient data, and deal terms.

Enforceability varies by state. Four states, California, North Dakota, Oklahoma, and Minnesota, ban non-competes entirely, with limited exceptions for business sales. Texas Senate Bill 1318, effective September 1, 2025, limits dental non-competes signed on or after that date to a five-mile radius, one-year maximum duration, and a mandatory buyout option capped at the dentist’s total annual salary. Senior partners in these states can benefit from working with dental-specific legal counsel to understand what protections remain available.

A phase-out period is a related negotiation point. This is the time the senior partner continues working post-close to transition patient relationships. Most DSO transactions require the selling dentist to continue practicing post-close for a defined period of 3–5 years under an employment agreement, while doctor-to-doctor walk-away sales typically involve only a 4–8 week work-back.

Speak with a McLerran & Associates advisor about your covenant terms to see how they can be structured in your state and market.

Key Protections for Senior Partners in Buyout Agreements

Senior partners selling after decades of practice often have specific vulnerabilities that standard buyout templates do not fully address. Explicit protections in the buy-sell agreement can significantly affect the financial and personal outcome of the transition.

Common senior-partner protections to consider include the following items.

• Guaranteed minimum price: This is a floor valuation written into the agreement, which helps ensure the senior partner receives no less than a defined amount regardless of post-close performance. This protection can be especially helpful when a portion of consideration is tied to earnouts.
• Continued profit participation: In partnership vest-out structures, where the senior partner sells approximately 50% now and the remainder over time, the departing doctor typically continues receiving a share of practice distributions during the transition period. Many dental partnership buyouts structure payment as a 20–30% down payment with the balance paid over 3–5 years at a defined interest rate. During that time, profit-sharing rights can sometimes be preserved.
• Health insurance continuation: Continued coverage under the practice’s group health plan through the transition period or until Medicare eligibility can be a meaningful benefit and is often negotiable.
• Non-punitive earnout terms: When earnouts are present, senior partners can negotiate pro-rata provisions, meaning a near-miss on an EBITDA target still pays most of the earnout. A later start date can also account for integration disruption. Earnout structures in dental deals commonly tie 10–25% of enterprise value to 12–24 month performance metrics. Shorter earnout windows and more objective metrics can reduce risk to the seller.
• Right of first refusal: Right of first refusal provisions in dental partnership agreements ensure that if one partner wants to sell equity to an outside buyer, the remaining partner can match the offer before the sale proceeds. This protection can prevent an unwanted third party from entering the practice.
• Death and disability carve-outs: Dental practice sale contracts can address what happens if the seller becomes disabled or dies during the non-compete period, including whether the restriction is suspended or extinguished.

McLerran & Associates negotiates these protections on behalf of selling doctors as part of every engagement. Because the firm works exclusively on the sell side, its incentives align with the senior partner rather than the buyer.

Get personalized guidance from McLerran & Associates to identify which senior-partner protections may fit your situation.

Redemption vs. Cross-Purchase in Multi-Partner Practices

When a senior partner exits a multi-owner dental practice, the buy-sell agreement will usually specify one of two legal structures for how the buyout is executed. The difference between these structures can affect taxes, insurance costs, and the net proceeds the retiring doctor receives.

A redemption agreement, also called an entity-purchase agreement, means the practice entity itself buys back the senior partner’s ownership interest. A cross-purchase agreement means the remaining individual partners buy the departing partner’s interest directly from them.

Dimension	Redemption Agreement	Cross-Purchase Agreement	Relevance for Retiring Senior Partner
Who buys the interest	The practice entity	The remaining individual partners	Affects who holds the obligation to pay
Tax basis for remaining partners	No step-up in basis for remaining partners	Remaining partners receive a stepped-up cost basis in the acquired interest	Cross-purchase can reduce future capital gains for buyers and may make the deal more attractive to them
Life insurance funding	Entity owns and pays premiums on one policy per partner	Each partner owns a policy on every other partner, so more policies are required	Redemption is simpler to administer in larger partnerships
Proceeds to retiring partner	Paid by the entity and may be treated partly as ordinary income depending on structure	Paid by individuals and more likely to qualify for capital gains treatment	Cross-purchase can produce a more favorable tax outcome for the seller, subject to CPA advice
Complexity with multiple partners	Simpler, with one transaction	More complex, as each remaining partner executes a separate purchase	Redemption is often preferred in practices with three or more partners
Lender considerations	Entity debt may affect practice credit capacity	Individual partners finance their own purchases	Cross-purchase can preserve the entity balance sheet for future borrowing

Neither structure is universally superior. The right choice can depend on the number of partners, the practice’s entity type such as S-corp, LLC, or professional corporation, the tax situation of all parties, and how the buyout is financed. Senior partners can benefit from working with a dental-specific CPA and attorney before the buy-sell agreement is drafted rather than after.

Contact McLerran & Associates to be connected with advisors who understand the dental-specific tax and structural implications of your exit.

Senior-Partner Buyout Checklist

A structured checklist can help senior partners organize the key decisions, documents, and protections covered in this guide before entering any negotiation. The items below reflect the core preparation steps McLerran & Associates works through with many clients.

1. Obtain a CPA-led, diligence-grade EBITDA analysis rather than a free, back-of-the-napkin estimate.
2. Request a side-by-side valuation in both the doctor-to-doctor and DSO markets.
3. Confirm your state’s non-compete enforceability rules with dental-specific legal counsel.
4. Define the buyout structure, redemption versus cross-purchase, with your CPA before the LOI is signed.
5. Negotiate senior-partner protections such as a guaranteed minimum price, earnout floor, health insurance continuation, and death or disability carve-outs.
6. Review the full payment timeline, including down payment, seller note terms, rollover equity lock-up period, and earnout measurement window.
7. Confirm the buyer’s financial qualification, whether an individual dentist or a DSO, before granting exclusivity.
8. Engage a sell-side advisor who creates competition among multiple qualified buyers rather than presenting a single offer.

McLerran & Associates has guided dental practice owners through roughly 2,000 successful sales totaling approximately $2 billion in closed transaction volume across roughly 35 years. The firm has evaluated more than 10,000 practices and maintains a transaction rate of approximately 85–90%, compared to an industry norm closer to 35–40%. That track record rests on a simple principle: the firm does not just list practices, it focuses on selling them.

Conclusion

Typical dental partnership buyout terms for senior partners in 2026 follow a consistent framework. Valuation benchmarks vary by buyer type and practice scale, payment structures differ between private buyers and DSOs, restrictive covenants sit within state-specific limits, and senior-partner protections can be negotiated to address common risks.

The difference between a good outcome and a great one often comes down to whether the senior partner has a sell-side advocate running a competitive process or is negotiating alone against a buyer who does this work every week.

To discuss your practice, your goals, and your options in a free, confidential conversation, contact McLerran & Associates directly. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us to request a confidential discovery call.

Frequently Asked Questions

What is a typical buyout timeline for a senior dental partner in 2026?

The timeline depends on the buyer type. Doctor-to-doctor transactions typically close in 60–120 days from a signed letter of intent, with the senior partner working back approximately 4–8 weeks post-close before exiting. DSO dental transactions generally take 3 to 6 months because of corporate diligence. In partnership vest-out structures, where the senior partner sells approximately 50% now and the remainder over time, the full exit can span 3–5 years, during which the departing doctor continues practicing and receiving a share of distributions. The phase-out period in DSO deals is typically 3–5 years, with most buyers requiring a post-close employment agreement to support clinical continuity and patient retention.

How is the senior partner’s equity stake valued differently from a full-practice sale?

In a partial-interest buyout, where one partner buys out another in an ongoing practice, the valuation methodology is usually the same as a full-practice sale. The structure often uses either a percentage of collections for doctor-to-doctor deals or a multiple of adjusted EBITDA for DSO-scale transactions. Partial-interest buyouts can involve a minority discount, meaning a 50% ownership stake may not be valued at exactly 50% of the whole-practice value if the buyer perceives reduced control.

Well-drafted partnership agreements address this issue by specifying the valuation formula upfront, whether a multiple of trailing 12-month collections, an EBITDA-based calculation, or an independent appraisal. This approach limits the ability of either party to manipulate the number at the time of exit. Senior partners who did not negotiate a defined formula when they entered the partnership are often in a weaker position and can benefit from independent, diligence-grade valuation work before any buyout discussion begins.

Can a senior partner negotiate to keep working part-time after the buyout closes?

Part-time work after closing is common in both doctor-to-doctor and DSO transactions. In a doctor-to-doctor walk-away sale, the senior partner typically works back 4–8 weeks to transition patient relationships, though longer arrangements can be negotiated. In DSO affiliations, a post-close employment agreement of 3–5 years is standard, and many senior partners find they can negotiate a reduced clinical schedule, such as fewer days per week or a gradual step-down, rather than an abrupt exit.

The key is to define the schedule, compensation, and exit conditions in writing before the letter of intent is signed rather than after. Vague language such as “part-time arrangement to be determined” can give the buyer leverage to define the terms later. Senior partners who want to wind down gradually may want to treat the post-close employment agreement as a core negotiation item.

What happens to the seller note if the buying partner defaults or the practice underperforms?

Seller notes in dental practice buyouts are almost always subordinated to the primary bank or SBA loan. This means that if the buyer defaults on the senior lender, seller note payments can be deferred or stopped entirely. This risk is real and senior partners may want to understand it clearly before accepting seller financing as part of their buyout proceeds.

Protections that can be negotiated include a second lien on practice assets such as equipment and patient records, a personal guarantee from the buying partner, a clause that triggers acceleration of the full note balance if the buyer misses a defined number of payments, and a provision that voids the non-compete if the buyer defaults and the seller is forced to repossess. Unsecured seller notes, which lack any lien on practice assets, are a significant red flag and are usually best avoided. Working with a dental-specific attorney to structure the note correctly can be as important as negotiating the purchase price itself.

Is now a good time for a senior dental partner to sell in 2026?

Demand for premier dental practices remains strong in 2026. Valuations for well-run, associate-supported practices with strong hygiene systems and favorable payer mix are near historically high levels, and a significant share of active buyers have indicated they expect to complete acquisitions or recapitalizations within the next 12–36 months. This environment can create a genuine seller’s window for owners of healthy practices.

The market is also increasingly selective. Valuation dispersion has widened, meaning the gap between the best offer and a middle-tier offer has grown, and process quality, or how a practice is taken to market, is increasingly a determining factor in outcome. Senior partners who wait for a perfect moment risk missing the current window, while those who move quickly to a single buyer without creating competition may leave significant value on the table. A well-informed decision usually starts with a current, diligence-grade valuation that quantifies what the practice may be worth in both the private-buyer and DSO markets today.